Author
Listed:
- Roberto Lande
(Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità
University Hospital CHUV)
- Elisabetta Botti
(Dermatology Unit, Sapienza University of Rome)
- Camilla Jandus
(Translational tumor immunology group, Ludwig center for cancer research of the University of Lausanne)
- Danijel Dojcinovic
(TC Metrix)
- Giorgia Fanelli
(University La Sapienza)
- Curdin Conrad
(University Hospital CHUV)
- Georgios Chamilos
(University of Texas MD Anderson Cancer Center)
- Laurence Feldmeyer
(University Hospital CHUV)
- Barbara Marinari
(University Tor Vergata)
- Susan Chon
(University of Texas MD Anderson Cancer Center)
- Luis Vence
(University of Texas MD Anderson Cancer Center)
- Valeria Riccieri
(University La Sapienza)
- Phillippe Guillaume
(TC Metrix)
- Alex A. Navarini
(University Hospital of Zurich)
- Pedro Romero
(TC Metrix)
- Antonio Costanzo
(Dermatology Unit, Sapienza University of Rome
Translational tumor immunology group, Ludwig center for cancer research of the University of Lausanne)
- Enza Piccolella
(University La Sapienza)
- Michel Gilliet
(University Hospital CHUV)
- Loredana Frasca
(Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità
University Hospital CHUV)
Abstract
Psoriasis is a common T-cell-mediated skin disease with 2–3% prevalence worldwide. Psoriasis is considered to be an autoimmune disease, but the precise nature of the autoantigens triggering T-cell activation remains poorly understood. Here we find that two-thirds of patients with moderate-to-severe plaque psoriasis harbour CD4+ and/or CD8+ T cells specific for LL37, an antimicrobial peptide (AMP) overexpressed in psoriatic skin and reported to trigger activation of innate immune cells. LL37-specific T cells produce IFN-γ, and CD4+ T cells also produce Th17 cytokines. LL37-specific T cells can infiltrate lesional skin and may be tracked in patients blood by tetramers staining. Presence of circulating LL37-specific T cells correlates significantly with disease activity, suggesting a contribution to disease pathogenesis. Thus, we uncover a role of LL37 as a T-cell autoantigen in psoriasis and provide evidence for a role of AMPs in both innate and adaptive immune cell activation.
Suggested Citation
Roberto Lande & Elisabetta Botti & Camilla Jandus & Danijel Dojcinovic & Giorgia Fanelli & Curdin Conrad & Georgios Chamilos & Laurence Feldmeyer & Barbara Marinari & Susan Chon & Luis Vence & Valeria, 2014.
"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis,"
Nature Communications, Nature, vol. 5(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6621
DOI: 10.1038/ncomms6621
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Anissa Fries & Fanny Saidoune & François Kuonen & Isabelle Dupanloup & Nadine Fournier & Ana Cristina Guerra de Souza & Muzlifah Haniffa & Feiyang Ma & Johann E. Gudjonsson & Lennart Roesner & Yang Li, 2023.
"Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis,"
Nature Communications, Nature, vol. 14(1), pages 1-14, December.
- A. Schäbitz & C. Hillig & M. Mubarak & M. Jargosch & A. Farnoud & E. Scala & N. Kurzen & A. C. Pilz & N. Bhalla & J. Thomas & M. Stahle & T. Biedermann & C. B. Schmidt-Weber & F. Theis & N. Garzorz-St, 2022.
"Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases,"
Nature Communications, Nature, vol. 13(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6621. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.